細胞拡張市場の市場規模、シェア、成長分析：製品別、細胞の種類別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

細胞拡張市場規模は2023年に304億米ドルと評価され、2024年の335億3,000万米ドルから2032年には734億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは10.3％で成長する見通しです。

細胞拡張市場は、細胞治療処理ソリューションの進歩に牽引され、信頼性の高い結果を提供しながら業務を合理化し、コストを削減することで大きな成長を遂げています。主要企業は、急増する細胞・遺伝子治療の世界の需要に対応するため、製品ラインアップを拡充しています。シングルユースシステム（SUS）へのシフトは生産性を向上させ、交差汚染のリスクを最小限に抑え、より低い長期コストでより高い細胞密度の生産を促進します。SUSの採用増加はこの勢いを支え、ライフサイエンス分野での細胞治療人気をさらに後押ししています。民間および政府組織からの旺盛な投資と、細胞治療開発を支援するイニシアティブが、市場促進要因として不可欠です。さらに、国際幹細胞学会は資金調達機会の創出に取り組んでおり、米国の細胞拡張市場の上昇傾向を強めており、今後数年間は持続的なCAGRで成長すると予測されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

細胞拡張市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 消耗品
  • 試薬培地血清
  • その他の消耗品
• 培養フラスコと付属品
  • 組織培養フラスコ
  • バイオリアクターアクセサリ
  • その他の培養フラスコと付属品
• 機器
  • 自動化された細胞拡張システム
  • 細胞カウンター
  • 遠心分離機
  • バイオリアクター
  • その他の楽器

細胞拡張市場規模：細胞の種類別& CAGR（2025-2032）

• 市場概要
• 哺乳類
  • 人間
  • 幹細胞（SC）
  • 成人幹細胞
  • 胚性幹細胞
  • 誘導多能性幹細胞
  • 分化細胞
  • 動物
• 微生物
• その他

細胞拡張市場規模：用途別& CAGR（2025-2032）

• 市場概要
• バイオ医薬品
• 組織培養とエンジニアリング
• ワクチン製造
• 医薬品開発
• 遺伝子治療
• がん調査
• 幹細胞調査
• その他

細胞拡張市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• バイオ医薬品・バイオテクノロジー企業
• 調査機関
• 細胞バンク
• その他

細胞拡張市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific（US）
• Becton, Dickinson and Company（US）
• Lonza Group（Switzerland）
• Corning Incorporated（US）
• Merck KGaA（Germany）
• Sartorius Stedim Biotech SA（Germany）
• Terumo Corporation（Japan）
• Miltenyi Biotec GmbH（Germany）
• Danaher Corporation（US）
• Stemcell Technologies Inc.（Canada）
• Beckman Coulter Inc.（US）
• Takara Bio Inc.（Japan）
• RepliCel Life Sciences（Canada）
• NexImmune Inc.（US）
• Celltainer Biotech BV（Netherlands）
• Repligen Corporation（US）
• Getinge AB（Sweden）
• Bio-Techne Corporation（US）
• PromoCell GmbH（Germany）
• Himedia Laboratories（India）

結論と提言

Cell Expansion Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 33.53 billion in 2024 to USD 73.46 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The cell expansion market is witnessing significant growth driven by advancements in cell therapy processing solutions, which streamline operations and reduce costs while delivering reliable results. Key players are expanding their product offerings to accommodate the surging global demand for cell and gene therapies. The shift towards single-use systems (SUS) enhances productivity, minimizing cross-contamination risks and facilitating higher cell density production at lower long-term costs. Increased adoption of SUS supports this momentum, further propelling cell therapy popularity within the life sciences sector. Robust investments from private and government organizations, coupled with initiatives supporting cell therapy development, are vital market drivers. Furthermore, the International Society for Stem Cell Research is working to create funding opportunities, reinforcing the upward trend in the US cell expansion market, projected to grow at a sustainable CAGR in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Expansion market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Expansion Market Segments Analysis

Global Cell Expansion Market is segmented by Product, Cell Type, Application, End Use and region. Based on Product, the market is segmented into Consumables, Culture Flasks and Accessories and Instruments. Based on Cell Type, the market is segmented into Mammalian, Microbial and Others. Based on Application, the market is segmented intobiopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research and Others. Based on End Use, the market is segmented into Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Expansion Market

The rapid adoption of cell expansion techniques in biopharmaceutical development represents a significant growth catalyst for the market. Key products like monoclonal antibodies, vaccines, and cell-based therapies are dependent on efficient and scalable cell expansion processes. Additionally, the rising incidence of chronic illnesses and the growing global demand for personalized medicine are driving the need for high-quality biopharmaceuticals. This trend underscores the importance of advanced cell expansion methods, as they are crucial for producing the necessary biological materials to meet the evolving healthcare demands. As such, the cell expansion market is positioned for considerable growth in the coming years.

Restraints in the Cell Expansion Market

One significant restraint in the Cell Expansion market stems from the regulatory and ethical challenges associated with cell-based therapeutic technologies. The development and marketing of such cell-based products necessitate adherence to stringent regulatory guidelines, which can differ considerably from one region to another. Furthermore, ethical dilemmas surrounding the use of embryonic stem cells and gene-editing methods pose considerable barriers to research and development activities in this field. These factors collectively limit the pace of innovation and commercialization in the Cell Expansion market, making it imperative for stakeholders to navigate these complexities effectively.

Market Trends of the Cell Expansion Market

The cell expansion market is witnessing a significant trend towards the adoption of 3D cell culture and bioreactor technologies, as researchers and biopharmaceutical companies pivot from conventional 2D culture systems. This shift is driven by the enhanced ability of 3D cultures to more accurately replicate the physiological microenvironment of cells, thereby improving cell function, viability, and behavior. This innovation is particularly transformative in areas such as regenerative medicine, cancer research, and drug development, where more realistic cellular models can yield more reliable data and outcomes. As technology evolves, its integration into various applications is expected to propel market growth and expand its potential.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Expansion Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents, Media, & Serum
  • Other Consumables
• Culture Flasks and Accessories
  • Tissue Culture Flasks
  • Bioreactor Accessories
  • Other Culture Flasks and Accessories
• Instruments
  • Automated Cell Expansion Systems
  • Cell Counters
  • Centrifuges
  • Bioreactors
  • Other Instruments

Global Cell Expansion Market Size by Cell Type & CAGR (2025-2032)

• Market Overview
• Mammalian
  • Human
  • Stem Cells (SCs)
  • Adult SCs
  • Embryonic SCs
  • Induced Pluripotent SCs
  • Differentiated Cells
  • Animal
• Microbial
• Others

Global Cell Expansion Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Gene Therapy
• Cancer Research
• Stem Cell Research
• Others

Global Cell Expansion Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical & Biotechnology Companies
• Research Institutes
• Cell Banks
• Others

Global Cell Expansion Market Size & CAGR (2025-2032)

• North America (Product, Cell Type, Application, End Use)
  • US
  • Canada
• Europe (Product, Cell Type, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius Stedim Biotech SA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RepliCel Life Sciences (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexImmune Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celltainer Biotech BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations